BioSpace News Archive

Datavant, the leader in helping healthcare organizations safely connect their data, and EVERSANA, the pioneer of next generation commercial services to the global life sciences industry, announced a strategic partnership in which EVERSANA will use Datavant’s data linking technology to enhance its advanced analytics capabilities.

The American Cancer Society held their 2020 Taste of Hope, an annual event that brings award-winning chefs and Chicago foodies together, to celebrate the charity’s fight against cancer.

Reduces the Complexity of Reporting for Screening and Diagnostic MRI Exams to Deliver Time-Saving and Patient Safety Benefits

The National Pharmaceutical Council (NPC) today announced that Michael L. Ryan , PharmD, Senior Vice President, Worldwide Value, Access, Pricing and Health Economics and Outcomes Research at Bristol Myers Squibb (BMS), has been elected Chair of NPC’s Board of Directors for 2020-2021. Dr. Ryan has previously served in several leadersh

Denovo Biopharma, a pioneer in applying precision medicine to development of innovative therapies, today announced that its international Phase 3 registrational study for DB102 has fully enrolled

Bridge Medicines receives $10 million capital infusion from investors Takeda Pharmaceutical Company Ltd., Bay City Capital, and Deerfield

Densitas® Inc., a leading provider of A.I. technologies for digital mammography and breast screening, announced today that NorthShore University HealthSystem (NorthShore), will deploy the densitas® intelliMammo™ platform across its mammography facilities.

American Regent, Inc., a Daiichi Sankyo Group company, announced that Ken Keller, currently serving as the company’s President and CEO, is transitioning to a new role as the Global Head of Oncology Business at Daiichi Sankyo, Inc. effective April 1, 2021.

Immunexpress, Inc., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, today announced that it will present data in two posters and host a workshop at the Association for Molecular Pathology (AMP) 2020 Annual Meeting & Expo taking place virtually on Nov. 16-20, 2020.

Soteria Biotherapeutics, Inc. (“Soteria”), a privately-held, immuno-oncology company focused on developing a next generation of conditionally active bispecific t-cell engaging antibodies to treat cancer patients with solid tumors, today announced the formation of a scientific advisory board to help guide the company’s early stage research and development.